# Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management

> **NCT05200546** · — · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 3921 (actual)

## Conditions studied

- Multidrug-resistant Bacteria Screening

## Interventions

- **DIAGNOSTIC_TEST:** molecular assays to screen for eXDR

## Key facts

- **NCT ID:** NCT05200546
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-18
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 3921 (ACTUAL)
- **Last updated:** 2023-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05200546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05200546, "Carbapenemase-Producing Organism and Vancomycin-Resistant Enterococcus Management". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05200546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*